<DOC>
	<DOCNO>NCT00931710</DOCNO>
	<brief_summary>This study compare antihypertensive efficacy safety valsartan/amlodipine-based treatment losartan-based treatment patient Stage 2 systolic hypertension ( high blood pressure , mean systolic blood pressure great 160 less 200 mmHg ) .</brief_summary>
	<brief_title>Valsartan/Amlodipine As Compared Losartan Treatment Stage 2 Systolic Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Male female outpatient 18 year age great Stage 2 systolic hypertension define office Mean Sitting Systolic blood pressure ( MSSBP ) great equal 160 &lt; 200 mmHg randomization Patients able participate study , give write informed consent study assessment perform . Office systolic blood pressure &gt; 200 and/or mean sit diastolic blood pressure ( MSDBP ) great equal 110 mmHg Visit 1 . Use four ( 4 ) antihypertensive medication within 30 day Visit 1 . Refractory hypertension , define blood pressure &gt; 140/90 mmHg take three ( 3 ) drug maximum dose drug , one must diuretic . ( Therapy fixeddose combination two active medication represent two drug ) . Inability safely discontinue antihypertensive medication 12 week prior randomization . Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>combination therapy</keyword>
	<keyword>valsartan</keyword>
	<keyword>cardiovascular disease</keyword>
</DOC>